Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Micrel Medical Devices Danmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.0% 0.0% 4.3% 3.5% 3.1% 3.8% 11.9% 11.9%   Credit score (0-100)   0 0 47 52 56 50 20 20   Credit rating   N/A N/A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 2,741 1,631 1,631 2,249 0.0 0.0   EBITDA   0.0 0.0 445 152 152 186 0.0 0.0   EBIT   0.0 0.0 425 121 121 141 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 424.5 117.0 117.0 139.8 0.0 0.0   Net earnings   0.0 0.0 329.3 91.0 91.0 107.3 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 424 117 117 140 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 158 281 281 153 0.0 0.0   Shareholders equity total   0.0 0.0 369 537 537 644 604 604   Interest-bearing liabilities   0.0 0.0 187 198 198 48.3 0.0 0.0   Balance sheet total (assets)   0.0 0.0 940 785 785 910 604 604   Net Debt   0.0 0.0 -375 -180 -180 -384 -604 -604     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 2,741 1,631 1,631 2,249 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% -40.5% 0.0% 37.9% -100.0% 0.0%   Employees   0 0 3 2 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% -33.3% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 940 785 785 910 604 604   Balance sheet change%   0.0% 0.0% 0.0% -16.4% 0.0% 15.9% -33.6% 0.0%   Added value   0.0 0.0 444.9 151.8 151.8 185.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 137 93 -31 -173 -153 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 15.5% 7.4% 7.4% 6.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 45.2% 14.1% 15.4% 16.6% 0.0% 0.0%   ROI %   0.0% 0.0% 75.6% 18.5% 16.2% 19.4% 0.0% 0.0%   ROE %   0.0% 0.0% 89.2% 20.1% 16.9% 18.2% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 39.3% 68.4% 68.4% 70.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% -84.3% -118.3% -118.3% -206.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 50.6% 36.8% 36.8% 7.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.1% 2.2% 2.1% 1.0% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 2.1 2.2 2.2 3.0 0.0 0.0   Current Ratio   0.0 0.0 2.1 2.2 2.2 3.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 561.9 377.2 377.2 432.3 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 404.0 270.6 270.6 503.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 N/A 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 148 76 76 62 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 148 76 76 62 0 0   EBIT / employee   0 0 142 61 61 47 0 0   Net earnings / employee   0 0 110 46 46 36 0 0